FAQ

Factor VIII

Known as: AHG, Thromboplastinogen, Factor viii (antihemophilic factor, human) per i.u. 
Blood-coagulation factor VIII. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1947-2018
0102019472017

Related topics

Related topics

48 relations
Activated Partial Thromboplastin Time measurementDrug AllergyF8 geneF8 wt Allele
(More)

Narrower (27)

AdvateAdynovateAlphanateAntihemophilic Factor, Human Recombinant
(More)

Broader (3)

Blood Coagulation FactorCoagulantsGlycoproteins

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Factor VIII
Drug Allergy
physiological aspects
Glycoproteins
Blood Coagulation Factor
Activated Partial Thromboplastin Time measurement

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Determinants of C1q binding in the single antigen bead assay.
BACKGROUND A modified single antigen bead (SAB) assay measuring C1q binding to human leukocyte antigen antibodies has recently… (More)
Is this relevant?
2006
2006
Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification.
BACKGROUND Sensitive techniques are able to detect low levels of circulating antibodies. For many newer techniques, the clinical… (More)
  • table 3
  • table 1
  • table 2
Is this relevant?
2004
2004
Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
BACKGROUND : Desensitization protocols have been developed to allow successful kidney transplantation in sensitized recipients… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch.
Flow cytometric crossmatching (FCXM) and panel reactive antibody (PRA) screening techniques are more sensitive than anti-human… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive…
BACKGROUND Hyperacute rejection (HAR) and acute humoral rejection (AHR) remain recalcitrant conditions without effective… (More)
Is this relevant?
2000
2000
Sensitization and sensitivity: defining the unsensitized patient.
BACKGROUND Since the landmark studies of Patel and Terasaki in the late 1960s, pretransplant cross-matching has been performed by… (More)
Is this relevant?
1999
1999
Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome.
BACKGROUND At our transplant center, primary recipients of either a haplo-identical (haplo-ID) living related (LRD) or a… (More)
Is this relevant?
1997
1997
Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma.
Activation of the complement system may contribute to the pathogenesis of many diseases. Hence, an effective inhibitor of… (More)
Is this relevant?
Highly Cited
1975
Highly Cited
1975
Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor.
Cold-insoluble globulin (CI globulin) was purified from human plasma and identified on the basis of its sedimentation coefficient… (More)
  • figure 1
  • table I
  • figure 2
  • table II
  • figure 3
Is this relevant?
1965
1965
Production of high-potency concentrates of antihemophilic globulin in a closed-bag system.
 
Is this relevant?